Exelixis (EXEL)

$36.39 0.00 (0.00%)

20:00 EDT EXEL Stock Quote Delayed 30 Minutes

EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings Aug 6, 2024

EXEL stock results show that Exelixis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

7 Cheap Biotech Stocks With Major Upside Potential

Just Say No to Drugs: 3 Pharma Stocks to Avoid

EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024

Volume:

Previous Close $36.92

Market Cap 10.33B

PE Ratio 23.46

EPS 1.5513

Volume (Avg. Vol.) 2.80M

Day's Range $35.67 - $37.18

52-Week Range $20.14 - $40.02

Dividend & Yield N/A (N/A)

EXEL Stock Predictions, Articles, and Exelixis News

The Top 3 Biotech Stocks to Buy in April 2024

By Joel Lim, InvestorPlace Contributor Apr 27, 2024

Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success

By Rick Orford, InvestorPlace Contributor Mar 6, 2024

With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector.

The 3 Best Biotech Stocks to Buy in February 2024

By Viktor Zarev, InvestorPlace Contributor Feb 13, 2024

The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes.

3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024

By Alex Sirois, InvestorPlace Contributor Jan 21, 2024

These top-rated biotech stocks are going to be in high demand in January and in every other month in 2024.

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

By Chris Markoch, InvestorPlace Contributor Jan 18, 2024

These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

By Muslim Farooque, InvestorPlace Contributor Nov 9, 2023

Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.

3 Biotech Stocks With the Strongest Clinical Pipelines

By Ian Cooper, InvestorPlace Contributor Nov 8, 2023

Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.

3 Promising Biotech Stocks Flying Under the Radar

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Nov 8, 2023

Breakthroughs in healthcare are happening everyday, make sure you are keeping up to date on these under the radar biotech stocks.

Steady Eddies: 3 Low Beta Stocks for Long-Haul Gains

By Rick Orford, InvestorPlace Contributor Oct 2, 2023

Low-beta stocks provide an avenue for investors looking for long-term growth accompanied by low volatility.

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall

By Chris Markoch, InvestorPlace Contributor Sep 20, 2023

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

These Are the ONLY 3 Biotech Stocks to Consider in August 2023

By Muslim Farooque, InvestorPlace Contributor Aug 21, 2023

These biotech stocks to buy represent tremendous bets and are essentially fueling innovation and portfolio growth at the same time.

3 Biotech Stocks You’ll Regret Not Buying Soon

By Michael Que, InvestorPlace Contributor Aug 8, 2023

The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200…

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil

By John Blankenhorn, InvestorPlace Contributor Jul 29, 2023

There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Jul 20, 2023

These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector.

7 Biotech Stocks That Will Make You Rich in 10 Years

By Josh Enomoto, InvestorPlace Contributor Jan 18, 2023

Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor Dec 29, 2022

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor Oct 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

3 Biotech Stocks to Buy Now for Extraordinary Gains

By Muslim Farooque, InvestorPlace Contributor Sep 20, 2022

These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.

The 7 Best Biotech Stocks to Buy

By Dana Blankenhorn, InvestorPlace Contributor Sep 20, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 24, 2022

Good morning, trader! We're jumping into trading on Tuesday with an overview of the biggest pre-market stock movers this morning!

Exelixis (EXEL)

EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024

7 Cheap Biotech Stocks With Major Upside Potential

Just Say No to Drugs: 3 Pharma Stocks to Avoid

EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Exelixis (EXEL)

EXEL Stock Predictions, Articles, and Exelixis News

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Subscriber Sign in